Original language | English |
---|---|
Pages (from-to) | 107-109 |
Number of pages | 3 |
Journal | Biological Psychiatry |
Volume | 93 |
Issue number | 2 |
DOIs | |
Publication status | Published - 15 Jan 2023 |
Bibliographical note
Funding Information:CS has received funding from the Frankfurt Forschungs Förderung and has served as a subject-matter expert/specialist for Bristol-Myers Squibb. HAD has received funding from European Commission 7th Framework Program Grant No. EU-FP7-CP-IP-2008-222963 (MOODINFLAME) and Horizon 2020 Grant No. H2020-SC1-2016-2017/H2020-SC1-2017-Two-Stage-RTD (MOODSTRATIFICATION). JT reports no biomedical financial interests or potential conflicts of interest.